These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 16887362
21. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men. Hong SK, Han BK, Jeong JS, Jeong SJ, Moon KH, Byun SS, Lee SE. Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534 [Abstract] [Full Text] [Related]
22. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Lindsay RS, Westgate JA, Beattie J, Pattison NS, Gamble G, Mildenhall LF, Breier BH, Johnstone FD. Clin Endocrinol (Oxf); 2007 Mar; 66(3):322-8. PubMed ID: 17302863 [Abstract] [Full Text] [Related]
23. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro. Han HJ, Kang CW, Park SH. Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497 [Abstract] [Full Text] [Related]
24. IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb. Brevetti G, Colao A, Schiano V, Pivonello R, Laurenzano E, Di Somma C, Lombardi G, Chiariello M. Clin Endocrinol (Oxf); 2008 Dec; 69(6):894-900. PubMed ID: 18410545 [Abstract] [Full Text] [Related]
25. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis. Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S. J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037 [Abstract] [Full Text] [Related]
26. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM. Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949 [Abstract] [Full Text] [Related]
27. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome. Schoyer KD, Liu HC, Witkin S, Rosenwaks Z, Spandorfer SD. Fertil Steril; 2007 Jul; 88(1):139-44. PubMed ID: 17320874 [Abstract] [Full Text] [Related]
28. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP). Friedrich N, Alte D, Völzke H, Spilcke-Liss E, Lüdemann J, Lerch MM, Kohlmann T, Nauck M, Wallaschofski H. Growth Horm IGF Res; 2008 Jun; 18(3):228-37. PubMed ID: 17997337 [Abstract] [Full Text] [Related]
29. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer. Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM. Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098 [Abstract] [Full Text] [Related]
30. Leptin, insulin, insulin-like growth factors and their binding proteins in cord serum: insight into fetal growth and discordancy. Davidson S, Hod M, Merlob P, Shtaif B. Clin Endocrinol (Oxf); 2006 Nov; 65(5):586-92. PubMed ID: 17054458 [Abstract] [Full Text] [Related]
31. Free insulin-like growth factor-I and cognitive function in older persons living in community. Landi F, Capoluongo E, Russo A, Onder G, Cesari M, Lulli P, Minucci A, Pahor M, Zuppi C, Bernabei R. Growth Horm IGF Res; 2007 Feb; 17(1):58-66. PubMed ID: 17208483 [Abstract] [Full Text] [Related]
32. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates. Williams RM, Yuen K, White D, Mallard B, Dalton RN, Acerini CL, Dunger DB. Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235 [Abstract] [Full Text] [Related]
33. Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples. Hartog H, van der Graaf WT, Wesseling J, van der Veer E, Boezen HM. Clin Biochem; 2008 May; 41(7-8):636-9. PubMed ID: 18294961 [Abstract] [Full Text] [Related]
35. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study. Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson PM. Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224 [Abstract] [Full Text] [Related]
36. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM. Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540 [Abstract] [Full Text] [Related]
37. Relationship between umbilical cord blood insulin-like growth factors and anthropometry in term newborns. Hung TY, Lin CC, Hwang YS, Lin SJ, Chou YY, Tsai WH. Acta Paediatr Taiwan; 2008 Jul; 49(1):19-23. PubMed ID: 18581724 [Abstract] [Full Text] [Related]
38. Serum insulin-like growth factor I/free prostate specific antigen (IGF-I/fPSA) ratio enhances prostate cancer detection in men with total PSA 4.0-10.0 ng/ml. Zhigang Z, Jieming L, Su L, Wenlu S. J Surg Oncol; 2007 Jul 01; 96(1):54-61. PubMed ID: 17345593 [Abstract] [Full Text] [Related]
39. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults. Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Xue X, Kritchevsky SB, Newman AB, Psaty BM. J Am Geriatr Soc; 2008 Apr 01; 56(4):652-60. PubMed ID: 18312313 [Abstract] [Full Text] [Related]
40. Interleukin-6 and insulin-like growth factor system relationships and differences in the human placenta and fetus from the 35th week of gestation. Street ME, Seghini P, Ziveri MA, Fieni S, Volta C, Neri TM, Viani I, Bacchi-Modena A, Bernasconi S. Growth Horm IGF Res; 2006 Apr 01; 16(5-6):365-72. PubMed ID: 17101288 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]